Tired of caffeine crashes and brain fog? Neuro Energizer reviews explains how its binaural beats will help focus, relax and ...

Announcement no. 49/2025 Interim report Q3 2025 21 October 2025 Sveinn Sölvason, President and CEO, comments: "Sales in Q3 2025 amounted to USD 237 million, representing 11% reported growth, of which ...

ClearPoint Neuro reports first-quarter revenue of $8.4 million, beating analyst estimates of $8.2 million. The company reports a first-quarter loss of 22 cents per share, missing estimates for a loss ...

Earnings call TRUMY is preparing for the anticipated FDA approval of the Lacanbi auto-injector by month-end, with production and logistics ramping underway. Cardiovascular growth was volume-led, while ...

NEW YORK (Reuters) - Valeant Pharmaceuticals International said on Monday that it is considering the sale of its neurological pharmaceutical business and may also spin it off or take it private.

Earnings call TRUMY is preparing for the anticipated FDA approval of the Lacanbi auto-injector by month-end, with production and logistics ramping underway. Cardiovascular growth was volume-led, while ...